Home ›
Trademark Categories ›
Pharmaceuticals ›
2007 ›
ME ›
METOJECT
Trademark search for:
METOJECT
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2007-08-02 — Application filed
2007-10-12 — Sn assigned for sect 66a subseq desig from ib
2007-10-12 — Application filed
2007-11-08 — Assigned to examiner
2007-11-14 — Final disposition recorded
2007-11-15 — Office action issued
2007-11-15 — Office action issued
2007-11-15 — Office action issued
2007-12-06 — Office action issued
2008-03-03 — Attorney/dom.rep.revoked and/or appointed
2008-03-03 — Teas/email correspondence entered
2008-03-03 — Office action issued
2008-03-03 — Correspondence received in law office
2008-03-03 — Teas revoke/app/change addr of atty/dom rep received
2008-03-11 — Approved for pub - principal register
2008-03-25 — Assigned to lie
2008-03-25 — Law office publication review completed
2008-04-09 — Notice of publication
2008-04-29 — Published for opposition
2008-07-15 — Registered-principal register
2008-10-16 — Final disposition recorded
2008-11-03 — Final disposition recorded
2008-11-03 — Final disposition recorded
2012-10-23 — International registration renewed
2012-12-29 — Final disposition recorded
2015-02-20 — Cancelled section 71
2015-10-20 — Total invalidation of reg ext protection created
2015-12-11 — Generic madrid transaction sent to ib
2015-12-11 — Generic madrid transaction created
2016-01-04 — Total invalidation processed by the ib
2017-02-16 — New representative at ib received
2022-09-27 — Final status recorded
2023-04-18 — Death of international registration
2023-04-18 — Notification of effect of cancellation of intl reg mailed
Owner Information
medac Gesellschaft für klinische Spezialpräparate mbH
Wedel DE
medac Gesellschaft für klinische; Spezialpräparate mbH
DE
medac Gesellschaft für klinische; Spezialpräparate mbH
DE
Correspondent
Richard M. LaBarge Marshall, Gerstein & Borun LLP 233 S. Waker Drive Suite 6300 Sears Tower Chicago, IL 60606-6357
Filing Details
Filing Date:
2007-08-02
Status Date:
2022-09-27
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.